Suppr超能文献

撤稿文章:晚期(III/IV期)弥漫性大B细胞淋巴瘤患者的辅助放疗在利妥昔单抗时代可改善预后。

Retracted article: Adjuvant radiotherapy in patients with diffuse large B-cell lymphoma in advanced stage (III/IV) improves the outcome in the rituximab era.

作者信息

Avilès Agustin, Nambo Maria-Jesus, Calva Angel, Neri Natividad, Cleto Sergio, Silva Luis

机构信息

a Oncology Research Unit, Oncology Hospital National Medical Center, IMSS , Mexico D.F. , Mexico.

b Department of Hematology , Oncology Hospital National Medical Center, IMSS , Mexico D.F. , Mexico.

出版信息

Hematology. 2019 Dec;24(1):521-525. doi: 10.1080/10245332.2018.1423880. Epub 2018 Jan 17.

Abstract

We, the Editor[s] and Publisher of Hematology, have retracted the following article: Avilès, A, Nambo, M-J, Calva, A, et al. Adjuvant radiotherapy in patients with diffuse large B-cell lymphoma in advanced stage (III/IV) improves the outcome in the rituximab era. Hematology. 2019;24:507-511; DOI: 10.1080/10245332.2018.1423880 The above article has been retracted as a result of concerns regarding the data upon which the presented research has been based. After re-examination and several independent expert reviews the consensus is that the data and results are not reliable and therefore the article must be retracted. The authors have agreed with this decision. We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as "Retracted".

摘要

我们,《血液学》杂志的编辑和出版商,已撤回以下文章:阿维莱斯,A,南博,M-J,卡尔瓦,A等。晚期(III/IV期)弥漫性大B细胞淋巴瘤患者的辅助放疗在利妥昔单抗时代可改善预后。《血液学》。2019年;24:507 - 511;DOI: 10.1080/10245332.2018.1423880。由于对该研究所依据的数据存在担忧,上述文章已被撤回。经过重新审查和多次独立专家评审,一致认为数据和结果不可靠,因此该文章必须撤回。作者已同意这一决定。我们在决策过程中参考了我们的出版伦理与诚信政策以及COPE关于撤稿的指南。被撤回的文章将继续在线以保留学术记录,但每页将添加数字水印标注为“已撤回”。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验